載入...
Targeting CARM1 in ovarian cancer with EZH2 and PARP inhibitors
Coactivator-associated arginine methyltransferase 1 (CARM1)-expressing high-grade serous ovarian cancers are characterized by poor prognosis and limited therapeutic options. Here we discuss a novel therapeutic strategy to target CARM1-expressing ovarian cancer based on a combination of poly (ADP-rib...
Na minha lista:
| 發表在: | Mol Cell Oncol |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7469455/ https://ncbi.nlm.nih.gov/pubmed/32944622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2020.1760675 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|